Daisy Wang, MPH, MBA is an international healthcare strategy and business development executive with over a decade of leadership experience across top global pharmaceutical, consulting, and financial organizations. Daisy earned a Master of Science in Analytical Chemistry from Stevens Institute of Technology (2011) and holds joint MBA degrees from The University of Hong Kong, Fudan University, and Melbourne Business School (2018). Her extensive industry career in Shanghai, China, includes leadership roles such as Assistant Manager at KPMG China, Senior BD Manager at Tasly Pharmaceutical Group, BD & PMO Manager for Healthcare Solutions at Boehringer Ingelheim, and Senior Manager of Market Access and Pricing Strategy for the Renal Business Unit at AstraZeneca. She currently serves as Vice President in the Transaction Management Department (Healthcare).

During her time at UCLA, Daisy contributed her global strategic expertise to key clinical and community health projects. For her summer consulting project, she collaborated with classmates Dayanara Nieto Flores and Nicole Morales to work alongside LA General Medical Center, developing actionable strategies to enhance care transitions and connect emergency department patients with primary care resources. Additionally, Daisy, Dayanara, and Nicole competed in the EMPH Sinaiko Business Plan Competition as the founders of Beyond Feet, an innovative street-medicine initiative that integrates specialized podiatric care with social support services to protect and empower unhoused individuals.

While pursuing her Executive MPH at UCLA, Daisy distinguished herself through academic and leadership excellence, earning induction into the Upsilon Phi Delta National Honor Society in Healthcare Management in 2025.